Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-01 Sale | 2025-07-02 4:34 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 25,123 | $0.2935 | $7,374 | 453,824 (Indirect Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:04 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 25,107 | $0.5619 | $14,108 | 478,947 (Indirect Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:47 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 5,032 | $0.566 | $2,848 | 179,054 (Indirect Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:38 pm | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-08 4:40 pm | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) | View |
| 2022-06-23 Sale | 2022-06-24 7:51 pm | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 7,960 | $2.69 | $21,412 | 148,244 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-30 Exercise | 2025-07-02 4:34 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 108,334 | $0 | 453,824 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:29 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 556,358 | $0 | 556,358 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:04 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 108,333 | $0 | 478,947 (Direct) | View |
| 2024-10-03 Option Award(A) | 2024-10-03 9:50 pm | N/A 2034-10-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-03 7:07 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:47 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 20,000 | $0 | 179,054 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 5:05 pm | N/A 2034-02-14 | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 20,000 | $0 | 164,086 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:40 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 20,000 | $0 | 164,086 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 7:33 pm | N/A 2033-01-26 | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 425,000 | $0 | 573,906 (Direct) | View |
| 2022-11-18 Option Award | 2023-01-31 7:33 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 662 | $2.74 | 573,906 (Direct) | View |
| 2022-05-18 Option Award | 2022-06-24 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 757 | $7.06 | 148,244 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 20,000 | $0 | 148,244 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:06 pm | N/A 2032-01-26 | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 400,000 | $0 | 535,447 (Direct) | View |
| 2021-11-18 Option Award | 2022-01-31 5:06 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 885 | $12.51 | 535,447 (Direct) | View |
| 2021-05-18 Option Award | 2021-08-19 5:05 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer | 867 | $14.45 | 235,442 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 5:05 pm | N/A 2029-08-14 | Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer | 50,440 | $0 | 235,442 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 5:05 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer | 50,440 | $1.35 | 235,442 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 5:36 pm | N/A 2031-02-17 | Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-09-22 Conversion | 2020-09-22 5:15 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer | 32,815 | $0 | 70,129 (Direct) | View |
Ownership | 2020-09-17 8:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer | 0 | $0 | 281,232 (Direct) | View |